Powered by
-
GILD Stock Chart
Historical GILD Prices
Gilead Sciences Stock Analysis
Rating: Sell
Total Grade: D
Analysis Breakdown
| GILD Stock Grade: | D |
| Fundamental Grade: | D |
| Quantitative Grade: | C |
| GILD Earnings | |
| Earnings Growth: | F |
| Earnings Momentum: | F |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | D |
| GILD Financial Information | |
| Sales Growth: | F |
| Operating Margin Growth: | F |
| Cash Flow: | F |
| Return on Equity: | A |
Gilead Sciences Stock: Weekly View
| This Week: | D |
|---|---|
| Last Week: | D |
| Two Weeks Ago: | C |
GILD Stock predictions, Articles, and Gilead Sciences News
- From InvestorPlace
- From the Web
-
7 Stocks With Massive Earnings Potential - April 12, 2018
Ahead of a critical earnings season, I highlight seven of the top stock picks from the Street's best analysts. These are the stocks that are poised to soar on a beat-and-raise quarter, according to analysts who consistently crush the market. Continue…
-
5 Biotech Stocks With Amazing Pipelines - March 27, 2018
Biotech stocks are only as good as their pipeline. These five biotech companies are about to put out promising new drugs, with more products in the works. Continue…
-
Is Right Now the Time to Buy the Dip in the QQQ ETF? - March 27, 2018
The QQQ ETF has been hammered over the past week, just when things were looking so good. Time to buy the QQQ chart or hold off? Continue…
-
At $79.99, Gilead Sciences (GILD) a Hold - March 8, 2018
Gilead Sciences (GILD) a Hold at $79.99 based on the most current stock market ratings, and comparative pricing of its shares. Continue…
-
This week, Gilead Sciences (GILD) stays a Hold - March 1, 2018
At $78.73, Gilead Sciences (GILD) a Hold based on the most recent stock market ratings, and relative pricing of its shares. Continue…
-
Is Gilead Sciences, Inc. Stock Still a Solid Value Play? - February 8, 2018
Despite a weak fourth-quarter, Gilead Sciences (GILD) stock still has deep value. If its drug studies play out, it could return to growth sooner than expected. Continue…
-
Gilead Sciences, Inc. (GILD) Shares Slide on Weak Outlook - February 6, 2018
Gilead Sciences (GILD) shares fell slightly after hours as the company's full-year revenue is slated to be below the Wall Street consensus estimate. Continue…
-
5 Biotech and Pharmaceutical Stocks Going Bonkers - January 26, 2018
These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy. Continue…
-
No Reason To Rush Into Juno Therapeutics Inc Stock After This Big Pop - January 18, 2018
Celgene will very likely acquire Juno for somewhere north of $70 per share, but Juno stock is already priced accordingly. Continue…
-
3 Reasons Dividend-Monster Pfizer Inc. Could Explode Higher - January 12, 2018
A low valuation and a big dividend are two reasons to consider buying Pfizer stock. A third? Its compelling setup on the chart. Continue…
